← Open Payments lookup

JILL BRYANT: Open Payments

NPI 1053925537 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,106 in 141 payments from 29 companies in 2025. Trend: 2023 $2,003 · 2024 $2,390 · 2025 $3,106

Food & beverage: $3,106
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$343
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$330
Otsuka America Pharmaceutical, Inc.8$326
Lilly USA, LLC15$270
Axsome Therapeutics, Inc.14$222
Janssen Biotech, Inc.9$218
Eisai Inc.5$203
ABBVIE INC.18$201
Novo Nordisk Inc6$188
Amgen Inc.14$147

Products named: REXULTI, CAPLYTA, BREZTRI, TREMFYA, Leqembi, Auvelity, Ozempic, SPRAVATO.

Industry payments across MO — which companies pay providers there.